Here is an article about H.R. 4963 (IH) – Marijuana 1-to-3 Act of 2025, presented in a polite tone with relevant information:
New Legislation Introduced: The Marijuana 1-to-3 Act of 2025 Aims to Reschedule Cannabis
A significant piece of legislation, H.R. 4963, has been introduced in the U.S. House of Representatives, bearing the title “Marijuana 1-to-3 Act of 2025.” This bill, officially published by GovInfo.gov on August 15, 2025, proposes a notable shift in the federal classification of marijuana.
The core of the Marijuana 1-to-3 Act of 2025 centers on amending the Controlled Substances Act (CSA). Specifically, the bill aims to reschedule marijuana from its current classification as a Schedule I drug. Schedule I substances are, under federal law, defined as having a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision.
While the full text of the bill, available through GovInfo.gov, would provide a comprehensive understanding of its provisions, the title and initial publication suggest a move to reclassify cannabis to a lower, less restrictive schedule. The “1-to-3” designation in the bill’s title may allude to a specific proposed scheduling within the CSA’s existing categories, potentially moving it to Schedule III or a similarly less restrictive category. Such a rescheduling would have profound implications, acknowledging potential medical uses and potentially facilitating further research and development.
The introduction of H.R. 4963 represents a continued effort by lawmakers to address the evolving landscape of cannabis policy in the United States. As more states enact their own cannabis reform measures, federal legislative action is seen by many as a crucial step towards creating a unified and consistent national framework.
The legislative process dictates that this bill will now undergo various stages, including committee review, potential amendments, and votes in the House of Representatives. Should it pass the House, it would then proceed to the Senate for consideration. The journey of such a bill from introduction to potential enactment is often lengthy and involves extensive debate and public discourse.
This development is likely to be of considerable interest to a wide range of stakeholders, including patients who may benefit from medical cannabis, the burgeoning cannabis industry, researchers, and policymakers across the nation. We will continue to monitor the progress of H.R. 4963 as it moves through the legislative process.
H.R. 4963 (IH) – Marijuana 1-to-3 Act of 2025
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
govinfo.gov Congressional Bills published ‘H.R. 4963 (IH) – Marijuana 1-to-3 Act of 2025’ at 2025-08-15 02:04. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.